NEW YORK (GenomeWeb) – EKF Diagnostics today announced that it has received two new proposals regarding the sale of its point-of-care (POC) diagnostics business.

EKF said in a statement that it has received a second non-binding preliminary offer of $115 million to $125 million in cash for its POC diagnostics unit from an undisclosed third party.

In a separate statement, the firm said it has received a third non-binding preliminary proposal for the POC diagnostics business from Chinese firm Jinjing Group that may or may not lead to an offer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.